시간 | 강의제목 | 발표자 | 소속 |
---|---|---|---|
08:30~09:00 | Registration | ||
09:00~09:05 | Opening (Executive Vice President, SMC & General Director, Cancer Center) |
Woo Yong Lee, M.D. | SMC, Korea |
09:05~09:10 | Welcome Address (President & CEO Samsung Medical Center) |
Seung Woo Park, M.D. | SMC, Korea |
Session I. CAR T-cell therapy in lymphoid malignancy | Ki Woong Sung, M.D. | SMC, Korea | |
09:10~09:40 | Current status of CAR T-cell therapy in SMC | Won Seog Kim, M.D. | SMC, Korea |
09:40~10:10 | Approved and emerging CAR T-cell therapy in lymphoma |
Anna Sureda, M.D. | Institut Català d'Oncologia-Hospitalet, Barcelona, Spain |
10:10~10:40 | CAR T-cell therapy in pediatric malignancy | Hee Young Ju, M.D | SMC, Korea |
10:40~11:00 | Coffee Break | ||
Session II. CAR T-cell therapy in solid tumors | Joon Oh Park, M.D | SMC, Korea | |
11:00~11:30 | CAR T-cell therapy in gastric cancer | Changsong Qi, M.D. | Peking University, China |
11:30~12:00 | CAR T-cell therapy for solid tumors based on a new concept | Hiroshi Fujiwara, M.D. | Mie University, Japan |
12:00~13:00 | Lunch | ||
Session Ⅲ. CAR T-cell therapy for future clinical practice | Yeup Yoon, Ph.D. | SMC, Korea | |
13:00~13:30 | Practical issues of CAR T-cell therapy | Seok Jin Kim, M.D. | SMC, Korea |
13:30~14:00 | Reimagining the Future of Cancer Care with CAR-T | Bernd Eschgfaeller, Ph.D. | Novartis, Switzerland |
14:00~14:30 | Gene editing and CAR T-cell therapy | Dae Sik Kim, Ph.D. | Sungkyunkwan University, Korea |
14:30~14:50 | Coffee Break | ||
Session IV. Next generation CAR T-cell therapy | Won Seog Kim, M.D. | SMC, Korea | |
14:50~15:20 | Engineering Next-Generation CAR T-cell therapy for cancer therapy | Yvonne Chen, Ph.D. | University of California, Los Angeles, USA |
15:20~15:50 | Next Generation CAR T-cell therapy against hematological malignancies | Kyungho Choi, M.D. | SNU, Korea |
15:50~16:20 | iPSC-derived CAR T-cell therapy | Maria Themeli, M.D. | Cancer Center Amsterdam, Netherlands |
16:20~16:50 | Towards Next-generation T-cell Engineering for Cancer | Chan Hyuk Kim, Ph.D. | KAIST, Korea |
16:50~17:00 | Closing (Director, Division of Hematology-Oncology CAR T-cell Therapy Center) |
Won Seog Kim, M.D. | SMC, Korea |